Johnson & Johnson Is a Boring Stock That Pays You to Wait

Johnson & Johnson is not a flashy company--it does business in industries that are not going away any time soon. But boring is not necessarily bad when it comes to stock selection.

Jun 29, 2014 at 9:13PM

Foolish investors should love boring stocks because they make great candidates for long-term investments.  These kinds of companies are in easy to understand lines of business, in stable industries, and usually have proven track records of performance. Johnson & Johnson (NYSE:JNJ) is one of these boring companies.

Johnson & Johnson is in three lines of business: consumer products, pharmaceuticals, and medical devices and diagnostics. Johnson & Johnson is the company responsible for such hits as Splenda, Band-Aids, Rogaine, and Tylenol.  To help put the analysis in perspective, we will make comparisons to The Procter & Gamble Company (NYSE:PG).  Procter & Gamble and Johnson & Johnson are both consumer goods companies in similar lines of business with market caps of $213 billion and $300 billion, respectively.

This stock pays you to wait
Johnson & Johnson sports a dividend yield of 2.7% and is considered a defensive stock.  This means that its products have stable demand and generally perform well in all economic conditions. Its share price may not skyrocket when the economy booms, but it won't go bankrupt when the market tanks either. In other words, we're always going to need Band-Aids and Tylenol regardless of the state of the economy. Procter & Gamble has a yield of 3.2% and is also a defensive stock. 

Johnson & Johnson has increased its dividend in every one of the past 51 years throughout multiple bear markets .  An impressive stat, but Procter & Gamble has increased their dividend for 57 straight years. The two companies have paid their investors to wait by rewarding them with dividend hikes and stock buybacks. But just because there is a history of dividend hikes and buybacks does not mean they are sustainable or warranted. To gauge sustainability we need to look at free cash flow (FCF), the payout ratio, and FCF coverage.

FCF coverage = FCF / (dividends + share repurchases)

Johnson & Johnson  2007 2008 2009 2010 2011 2012 2013
FCF $12.1 billion  $11.9 billion  $14.2 billion  $14 billion  $11.4 billion $12.5 billion  $13.8 billion
Payout ratio 44%  39%  43%  44%  64%  63%  53%
FCF coverage 1.18 times  1.02 times  1.9 times  1.63 times  1.31 times  0.64 times  1.28 times
P&G 2007 2008 2009 2010 2011 2012 2013
FCF  $10.5 billion $12 billion  $11.7 billion  $13 billion  $10 billion  $9.3 billion  $10.9 billion 
Payout ratio  41%  39%  38%  43%  48%  56%  57%
FCF coverage  1.07 times  0.81 times  1.02 times  1.13 times  0.78 times  0.92 times  0.87 times

Here we have a seven-year period that encompasses the lead up to the financial crisis all the way up to its supposed recovery, the most recent year-end. Over the period, the compound annual growth rate of dividends per share for Johnson & Johnson and Procter & Gamble has been 8.13% and 10.18%, respectively. Neither company has a stated dividend policy meaning management decides how much to pay out after considering the cash needed to maintain operations without straining cash balance. The table demonstrates both company's FCF generation over different market conditions, but comparing them dollar for dollar does not provide any insight.  Next we will examine payout and coverage ratios to look at dividend sustainability. 

On average, Johnson & Johnson and Procter & Gamble have paid out 50% and 46%, respectively, of earnings in dividends over the period.  High payout ratios are fine, as long as they can be maintained with increased FCFs. The payout ratio does not include share repurchases, only dividends, but FCF coverage accounts for both.  A coverage of over 1 implies that the company is not lowering its cash balance to pay for dividends and repurchases. Also, a higher ratio lets investors feel more confident that the dividends and repurchases will continue. Johnson & Johnson has been above 1 on this metric in each year except 2012, when the ratio dipped to 0.64 times. This is because the company repurchased over $10 billion in stock that year.  Usually, a repurchase of this magnitude occurs when management believes the company's stock is undervalued and is seen as a good buying opportunity. Procter & Gamble's lower payout ratio does not translate into better FCF coverage like one would expect.  Procter & Gamble has been below 1 times coverage since 2010 which implies either the dividend or repurchase program may not be sustainable.    

Foolish takeaway
The takeaway here is that Johnson & Johnson has steady FCF generation which has led to 51 years straight of dividend increases and a history of stock buybacks.  Johnson & Johnson's dividend should be viewed as safe due to their FCF generation and restraint in not paying out unnecessarily large amounts of those FCFs.  Johnson & Johnson warrants a closer look for anyone who needs a long-term dividend play in their portfolios. For Johnson & Johnson, it pays to be boring.

Leaked: This coming consumer device can change everything
Imagine the multi-billion dollar sales potential behind a product that can revolutionize the way the world shops and interacts with its favorite brands every day. Now picture one small, under-the radar company at the epicenter of this revolution that makes this all possible. And its stock price has nearly an unlimited runway ahead for early, in-the-know investors. To be one of them and hop aboard this stock before it takes off, just click here.  


Zach Friesner has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information